## Gene Summary
ACP1, also known as Acid Phosphatase 1, encodes the enzyme low molecular weight phosphotyrosine protein phosphatase, which is involved in various cellular processes including cell growth, signal transduction, and apoptosis. ACP1 is located on chromosome 2p25 and exists in several isoforms due to alternative splicing. The enzyme functions by regulating the phosphorylation status of target proteins, thus modulating their activities. It is expressed ubiquitously in many tissues, suggesting its fundamental role in general cellular function.

## Gene Drugs, Diseases, Phenotypes, and Pathways
ACP1 has been implicated in a range of diseases and cellular pathways, primarily related to its role in cell signaling and immune system regulation. Research has linked ACP1 to conditions such as obesity, type 2 diabetes, and several inflammatory responses. Furthermore, ACP1 participates in modulating the T-cell receptor signaling pathway and has a significant role in adjusting the immune cell responses. This gene has also been associated with susceptibility to systemic lupus erythematosus and rheumatoid arthritis, indicating its influence in autoimmune disorders.

## Pharmacogenetics
In the context of pharmacogenetics, variations in the ACP1 gene have been studied for their impact on the response to various drugs. Notable associations exist with the response to antipsychotic medications, particularly in the treatment of schizophrenia, suggesting that ACP1 activity could influence drug efficacy and the occurrence of side effects. Additionally, ACP1 pharmacogenomics has been examined in relation to anti-inflammatory drugs, aligning with its role in inflammatory pathways. Studies have indicated that different isoforms of ACP1 might modulate the efficacy of these medications, potentially guiding personalized medicine strategies in inflammatory diseases. Although these findings are promising, further research is needed to fully integrate ACP1 genetic profiling in clinical practice for optimizing drug therapy.